Page 11 - Read Online

Paraskevas. Neuroimmunol Neuroinflammation 2020;7:183-93 I http://dx.doi.org/10.20517/2347-8659.2019.008 Page 189

standardized operating procedures and harmonization of diagnostic criteria used, as well as well-organized
and secure patient data sharing, are all required and pose challenges that should be faced by specialized
centers [111] .

DECLARATIONS
Authors’ contributions
The author contributed solely to the article.

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
The author declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. Pierce AL, Bullain SS, Kawas CH. Late-onset Alzheimer disease. Neurol Clin 2017;35:283-93.
2. Wallin A, Román GC, Esiri M, Kettunen P, Svensson J, et al. Update on vascular cognitive impairment associated with subcortical small-
vessel disease. J Alzheimers Dis 2018;62:1417-41.
3. Galasko D. Lewy body disorders. Neurol Clin 2017;35:325-38.
4. Karageorgiou E, Miller BL. Frontotemporal lobar degeneration: a clinical approach. Semin Neurol 2014;34:189-201.
5. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-
ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology
1984;34:939-44.
6. Lopez OL, Becker JT, Klunk W, Saxton J, Hamilton RL, et al. Research evaluation and diagnosis of probable Alzheimer’s disease over
the last two decades: I. Neurology 2000;55:1854-62.
7. Risse SC, Raskind MA, Nochlin D, Sumi SM, Lampe TH, et al. Neuropathological findings in patients with clinical diagnoses of probable
Alzheimer’s disease. Am J Psychiatry 1990;147:168-71.
8. Mendez M, Mastri AR, Sung JH, Frey WH. Clinically diagnosed Alzheimer’s disease: neuropathologic findings in 650 cases. Alzheimer
Dis Assoc Disord 1992;6:35-43.
9. Gilleard CJ, Kellett JM, Coles JA, Millard PH, Honavar M, et al. The St. George’s dementia bed investigation study: a comparison of
clinical and pathological diagnosis. Acta Psychiatr Scand 1992;85:264-69.
10. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, et al. The diagnosis of dementia due to Alzheimer’s disease:
recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s
disease. Alzheimers Dement 2011;7:263-69.
11. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the
IWG-2 criteria. Lancet Neurol 2014;13:614-29.
12. Paraskevas GP, Kaselimis D, Kourtidou E, Constantinides V, Bougea A, et al. Cerebrospinal fluid biomarkers as a diagnostic tool of the
underlying pathology of primary progressive aphasia. J Alzheimers Dis 2017;55:1453-61.
13. Constantinides VC, Paraskevas GP, Emmanouilidou E, Petropoulou O, Bougea A, et al. CSF biomarkers β-amyloid, tau proteins and
a-synuclein in the differential diagnosis of Parkinson-plus syndromes. J Neurol Sci 2017;382:91-5.
14. Constantinides VC, Paraskevas GP, Efthymiopoulou E, Stefanis L, Kapaki E. Clinical, neuropsychological and imaging characteristics of